Company intelligence / Profile preview

Bioventia

Ownership: Private
Development stage: Other

Overview

Bioventia operates as an independent life sciences consulting firm supporting early innovation in the sector. The company offers over 25 years of experience in drug discovery and development across various therapeutic modalities. It acts as a bridge between scientific ideas, innovation, financing, and competent management for projects and new businesses within the life sciences ecosystem[1][5]. Key personnel include Dr. Malmqvist (Chief Science Officer), who has significant experience in biomolecular science and business development[6].

Industry: Consulting

Partnerships

No specific partnerships disclosed; works broadly with innovators, startups, academia, and industry clients.

Beyond the preview

Go deeper on Bioventia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bioventia.

Explore the full profile